Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Breakthrough Coil Stops Brain Bleeds

Breakthrough Coil Stops Brain Bleeds - Providing Platinum Lifeline For Thousands

SYDNEY, Oct. 29 /MediaNet International-AsiaNet/ --


A minimally invasive tiny platinum coil is set to revolutionise the treatment of thousands of Australians stuck down by stroke caused by a ruptured brain aneurysm, following the results of major global trial involving Australian patients.

“This compelling data represents a turning point in how Australian doctors will treat thousands of patients who suffer from a ruptured brain aneurysm, the deadliest form of stroke,” said Professor Michael Morgan, Cerebrovascular Neurosurgeon, Royal North Shore Hospital, Sydney.

“Until recently, we relied on invasive brain surgery and placing a surgical clip at the neck of the anuerysm as the only form of effective treatment to prevent brain aneursyms re-bleeding.

“Now, endovascular coiling has become an important alternative treatment. With the results of this trial it is now clear that 50 per cent of all patients with ruptured aneurysms are best considered for treatment by endovascular coiling,” he said.

According to Professor Morgan, “The GDC™ coiling technology – which is inserted via a catheter into the main artery in the patient’s leg – travels directly to the brain where it locates the aneurysm and deploys a protective web that fills the damaged region with a stream of tiny platinum coil – creating a barrier that stops arterial blood escaping into the brain and preventing a full haemorrhagic stroke.”

In Australia it is estimated that as many as 500,000 people will develop a brain aneurysm during their lifetime. Every year more than 2,400 people suffer from ruptured brain aneurysms. Ten to 15 percent of these patients will die before reaching the hospital. More than 50 percent will die within the first 30 days after rupture. Of those who survive, approximately half will suffer permanent neurological deficit *1. The results of the landmark global study – International Subarachnoid Aneurysm Trial (ISAT) – published in The Lancet revealed that the risk of death or significant disability at one year for patients treated with platinum coils was 23 per cent percent lower than patients treated with traditional surgery– an absolute risk reduction of seven percent *2. According to Associate Professor Mark Khangure, Royal Perth Hospital, lead investigator of the Australian arm of the trial, “The data was so convincing, the trial was stopped early for ethical reasons due to the significant reduction in death and disability of trial patients treated with coil technology compared to those undergoing conventional micro-surgery.

“The study confirms that endovascular therapy significantly reduces the risk of brain damage when compared with traditional craniotomy procedures.

“Endovascular procedures undertaken at Royal Perth Hospital have seen patients recovery faster, have shorter hospital stays and return to normal daily work routines much earlier,” he added.

GDC™ endovascular coiling technology is available in 11 major medical centres in Australia, however only one-in-seven patients with a ruptured brain aneurysm currently receive endovascular coiling treatment.

Professor Morgan stressed it is imperative that appropriate patients with a brain haemorrhage should be transferred early to hospitals that provide endovascular coiling. “The average time between haemorrhage and treatment was one day in this major study,” he said.

“Ultimately, this innovative technology allows many lives to be saved and the disability and loss of mobility that results from haemorrhagic stroke significantly reduced in the first 12 months after treatment,” claimed Professor Khangure.

Target, a division of Boston Scientific is a leading developer of less-invasive medical technologies for endovascular neurosurgery and interventional neuroradiology. It manufactures coils, guidewires and catheters used to treat brain aneurysms. All of the endovascular patients in the study with one-year follow-up were treated using Target's GDCTM coil. Further information on the GDCTM coil is available on the Boston Scientific website at www.bostonscientific.com

# Ends #

© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 


Federated Farmers: NAIT Levy Increases Must Achieve Accurate, User-friendly System
Nobody welcomes extra costs but if OSPRI is to catch-up on under investment in the NAIT platform and deliver on its workability and farmer support, levy increases are probably necessary, Federated Farmers says... More>>



Westpac: More Job Opportunities, But Growth In Workers’ Earnings Remains Subdued

The Westpac McDermott Miller Employment Confidence Index rose 1.2 points in the December quarter, to a level of 106.9. This was the sixth straight rise in the index since the Covid-19 lockdown in 2020. Michael Gordon, Acting Chief Economist for Westpac, noted that the rise in the index has largely been driven by perceptions... More>>




Statistics: Card Spending Continues To Increase As COVID-19 Restrictions Ease

The busy Christmas period combined with easing COVID-19 restrictions helped to increase card spending in December 2021, Stats NZ said today... More>>

TradeMe: Job Market Ends 2021 On A High With Record Number Of Vacancies
The New Zealand job market finished 2021 on a high note, with the ball still firmly in the job hunters’ court, according to the analysis of 69,600 vacancies listed on Trade Me Jobs for the quarter ending 31 December (Q4)... More>>


Insurance Council of New Zealand: September South Island Windstorm Cost $36.5 M Raises 2021 Extreme Weather Claims Total To $321.6 M

Gale force winds and storms between 9 and 13 September 2021 resulted in insurers supporting communities to the tune of $36.5 m. This is a significant rise, of $16.7 m, on preliminary figures for the event and lifts the end of year total for all extreme weather events in 2021 to $321.6 m... More>>


Statistics: Building Consents Hit New Highs In November
There were a record 48,522 new homes consented in the year ended November 2021, Stats NZ said today. This was up 26 percent compared with the year ended November 2020... More>>